We provide you with 20 years of free, institutional-grade data for EYPT stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of EYPT. Explore the full financial landscape of EYPT stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$85,029
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|---|---|---|---|---|
| Lurker Nancy | Derivatives Exercise | 11,111 | 2025-07-11 | ||
| Duker Jay S. | Sale | -7,688 | $11.06 | $85,029 | 2025-07-11 |
| Duker Jay S. | Derivatives Exercise | 16,667 | 2025-07-11 | ||
| Zaderej Karen L. | Derivatives Exercise | 2,000 | 2025-07-11 | ||
| Elston George | Sale | -2,202 | $5.68 | $12,507 | 2025-05-27 |
| Elston George | Derivatives Exercise | 7,500 | 2025-05-27 | ||
| Zaderej Karen L. | Open Market Purchase | 10,000 | $5.81 | 2025-05-19 | |
| Zaderej Karen L. | Open Market Purchase | 10,000 | $5.42 | 2025-05-15 | |
| Duker Jay S. | Sale | -2,055 | $6.5 | $13,347 | 2025-02-11 |
| Duker Jay S. | Derivatives Exercise | 7,000 | 2025-02-11 | ||
| Lurker Nancy | Derivatives Exercise | 20,000 | 2025-02-11 | ||
| Elston George | Derivatives Exercise | 5,834 | 2025-02-11 | ||
| Elston George | Sale | -10,075 | $8.26 | $83,220 | 2025-01-07 |
| Elston George | Derivatives Exercise | 30,285 | 2025-01-07 | ||
| Landis John B. | Derivatives Exercise | 10,000 | 2025-01-07 | ||
| Lurker Nancy | Derivatives Exercise | 87,801 | 2025-01-07 | ||
| Duker Jay S. | Sale | -16,115 | $8.26 | $133,110 | 2025-01-07 |
| Duker Jay S. | Derivatives Exercise | 50,794 | 2025-01-07 | ||
| Zaderej Karen L. | Open Market Purchase | 12,500 | $7.98 | 2024-08-21 | |
| DICICCO WENDY F | Open Market Purchase | 2,567 | $7.79 | 2024-08-21 | |
| ANDO GORAN | Open Market Purchase | 5,000 | $7.95 | 2024-08-21 | |
| Lurker Nancy | Open Market Purchase | 3,173 | $7.88 | 2024-08-20 | |
| GUYER DAVID R | Sale | -11,625 | $10.06 | $116,995 | 2024-07-16 |
| GUYER DAVID R | Derivatives Exercise | 9,775 | 2024-07-16 | ||
| Lurker Nancy | Derivatives Exercise | 11,111 | 2024-07-12 | ||
| Zaderej Karen L. | Derivatives Exercise | 2,000 | 2024-07-12 | ||
| Duker Jay S. | Sale | -8,059 | $8.69 | $70,033 | 2024-07-12 |
| Duker Jay S. | Derivatives Exercise | 16,666 | 2024-07-12 | ||
| ADAMIS ANTHONY P | Derivatives Exercise | 2,000 | 2024-06-25 | ||
| GUYER DAVID R | Sale | -11,625 | $10.3 | $119,705 | 2024-06-04 |
| GUYER DAVID R | Derivatives Exercise | 9,775 | 2024-06-04 | ||
| Elston George | Sale | -3,627 | $11.16 | $40,477 | 2024-05-28 |
| Elston George | Derivatives Exercise | 7,500 | 2024-05-28 | ||
| GUYER DAVID R | Sale | -11,625 | $12.65 | $147,045 | 2024-05-16 |
| GUYER DAVID R | Derivatives Exercise | 9,775 | 2024-05-16 | ||
| Cormorant Asset Management, LP | Open Market Purchase | 850,000 | $11.7 | 2024-05-08 | |
| Cormorant Asset Management, LP | Open Market Purchase | 581,765 | $17.62 | 2024-04-22 | |
| Paggiarino Dario A. | Sale | -25,546 | $20.67 | $528,036 | 2024-04-02 |
| Paggiarino Dario A. | Derivatives Exercise | 50,404 | 2024-04-02 | ||
| Jones David Scott | Sale | -3,656 | $28.8 | $105,293 | 2024-02-13 |
| Jones David Scott | Derivatives Exercise | 9,967 | 2024-02-13 | ||
| Duker Jay S. | Sale | -3,533 | $28.8 | $101,750 | 2024-02-13 |
| Duker Jay S. | Derivatives Exercise | 11,967 | 2024-02-13 | ||
| Elston George | Sale | -3,192 | $28.8 | $91,930 | 2024-02-13 |
| Elston George | Derivatives Exercise | 10,800 | 2024-02-13 | ||
| Lurker Nancy | Sale | -14,943 | $28.8 | $430,358 | 2024-02-13 |
| Lurker Nancy | Derivatives Exercise | 37,534 | 2024-02-13 | ||
| Paggiarino Dario A. | Sale | -5,083 | $28.8 | $146,390 | 2024-02-13 |
| Paggiarino Dario A. | Derivatives Exercise | 10,800 | 2024-02-13 | ||
| Jones David Scott | Sale | -209 | $28.49 | $5,954 | 2024-02-05 |
| Jones David Scott | Derivatives Exercise | 209 | 2024-02-05 | ||
| Paggiarino Dario A. | Sale | -49,325 | $25.41 | $1,253,181 | 2024-01-30 |
| Paggiarino Dario A. | Derivatives Exercise | 49,325 | 2024-01-30 | ||
| Jones David Scott | Sale | -26,017 | $25.45 | $662,042 | 2024-01-29 |
| Jones David Scott | Derivatives Exercise | 26,017 | 2024-01-29 | ||
| Paggiarino Dario A. | Sale | -600 | $25 | $15,000 | 2024-01-29 |
| Paggiarino Dario A. | Derivatives Exercise | 600 | 2024-01-29 | ||
| Jones David Scott | Sale | -11,900 | $25.01 | $297,612 | 2024-01-26 |
| Jones David Scott | Derivatives Exercise | 11,900 | 2024-01-26 | ||
| Paggiarino Dario A. | Sale | -16,386 | $25 | $409,650 | 2024-01-25 |
| Paggiarino Dario A. | Derivatives Exercise | 16,386 | 2024-01-25 | ||
| Lurker Nancy | Sale | -35,000 | $24.97 | $873,957 | 2024-01-25 |
| Jones David Scott | Sale | -35,066 | $22.24 | $779,773 | 2024-01-24 |
| Jones David Scott | Derivatives Exercise | 35,066 | 2024-01-24 | ||
| Liu Ye | Sale | -1,910,500 | $19.45 | $37,159,225 | 2024-01-16 |
| Ocumension Therapeutics | Sale | -1,910,500 | $19.45 | $37,159,225 | 2024-01-16 |
| Cormorant Asset Management, LP | Open Market Purchase | 855,000 | $21.32 | 2024-01-11 | |
| Paggiarino Dario A. | Sale | -22,913 | $21.13 | $484,124 | 2024-01-10 |
| Paggiarino Dario A. | Derivatives Exercise | 22,913 | 2024-01-10 | ||
| Duker Jay S. | Sale | -6,528 | $20.4 | $133,171 | 2024-01-09 |
| Duker Jay S. | Derivatives Exercise | 20,793 | 2024-01-09 | ||
| Lurker Nancy | Sale | -23,043 | $20.4 | $470,077 | 2024-01-09 |
| Lurker Nancy | Derivatives Exercise | 75,133 | 2024-01-09 | ||
| Paggiarino Dario A. | Sale | -4,487 | $20.4 | $91,535 | 2024-01-09 |
| Paggiarino Dario A. | Derivatives Exercise | 15,285 | 2024-01-09 | ||
| Pine Michael Craig | Sale | -5,966 | $20.4 | $121,706 | 2024-01-09 |
| Pine Michael Craig | Derivatives Exercise | 15,285 | 2024-01-09 | ||
| Jones David Scott | Sale | -4,147 | $20.4 | $84,599 | 2024-01-09 |
| Jones David Scott | Derivatives Exercise | 15,285 | 2024-01-09 | ||
| Elston George | Sale | -4,911 | $20.4 | $100,184 | 2024-01-09 |
| Elston George | Derivatives Exercise | 15,285 | 2024-01-09 | ||
| Paggiarino Dario A. | Sale | -1,458 | $20 | $29,160 | 2023-12-15 |
| Paggiarino Dario A. | Derivatives Exercise | 1,458 | 2023-12-15 | ||
| Cormorant Asset Management, LP | Open Market Purchase | 588,235 | $17 | 2023-12-12 | |
| Pine Michael Craig | Sale | -46,000 | $22 | $1,012,000 | 2023-12-11 |
| Pine Michael Craig | Derivatives Exercise | 45,000 | 2023-12-11 | ||
| Ocumension Therapeutics | Sale | -1,000,000 | $19.91 | $19,910,000 | 2023-12-07 |
| Liu Ye | Sale | -1,000,000 | $19.91 | $19,910,000 | 2023-12-07 |
| Pine Michael Craig | Sale | -45,000 | $22 | $990,000 | 2023-12-06 |
| Pine Michael Craig | Derivatives Exercise | 45,000 | 2023-12-06 | ||
| Paggiarino Dario A. | Sale | -30,625 | $22 | $673,750 | 2023-12-06 |
| Paggiarino Dario A. | Derivatives Exercise | 30,625 | 2023-12-06 | ||
| Cormorant Asset Management, LP | Open Market Purchase | 1,919,057 | $18.8 | 2023-12-06 | |
| Lurker Nancy | Sale | -20,000 | $20.76 | $415,200 | 2023-12-06 |
| EW Healthcare Partners, L.P. | Sale | -40,000 | $9.9 | $395,964 | 2023-09-06 |
| EW Healthcare Partners, L.P. | Sale | -139,471 | $10.92 | $1,523,358 | 2023-09-01 |
| EW Healthcare Partners, L.P. | Sale | -148,712 | $11.71 | $1,741,432 | 2023-08-30 |
| EW Healthcare Partners, L.P. | Sale | -223,936 | $11.54 | $2,584,221 | 2023-08-30 |
| EW Healthcare Partners, L.P. | Sale | -223,936 | $14.62 | $3,273,653 | 2023-08-28 |
The information provided in this report about EYPT stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
EyePoint Pharmaceuticals, Inc(NASDAQ:EYPT) 
EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macula...
Website: http://eyepointpharma.com
Founded: 1987
Full Time Employees: 84
Sector: Healthcare
Industry: Biotechnology